“The clearance of NeuroRPM is a major milestone in the fight against Parkinson’s disease,” Alexander Ksendzovsky, MD, PhD, cofounder and chief scientific officer of NeuroRPM, the app’s developer, said in a company press release."
"The app runs on the Apple Watch and offers an easy and effective way to continuously monitor symptoms and other health metrics important for Parkinson’s disease, the company reported. Among symptoms captured by the wrist-worn device are bradykinesia, or abnormally slow movements; tremor; and dyskinesia, the uncontrolled and involuntary movements that can affect patients."
-----------------
Gastrointestinal dysfunction in Parkinson’s Disease: absence of anti-gliadin antibodies
What are your thoughts on RELYVRIO previously known as AMX0035? Could it benefit PD patients as well?
Good News - Drugs to address chronic inflammation and PD - NodThera
